Kidney360 · 2026
Length of Follow-Up Time Needed for Stable eGFR Slope Estimation in Glomerular Disease.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Liu Qian, Chen Allison, Mariani Laura H, Janowczyk Andrew, Lafata Kyle, Hodgin Jeffrey, Barisoni Laura, Holzman Larry B, Zee Jarcy, Cure Glomerulonephropathy (CureGN) Study
Аннотация
KEY POINTS: Several years of follow-up are necessary to accurately estimate long-term eGFR slopes in patients with glomerular disease. Moderately sized gaps between eGFR measurements are acceptable when estimating long-term eGFR slopes.
BACKGROUND: Slope of eGFR is an important measurement of kidney disease progression and clinical outcome in glomerular disease. However, the length of time required to reliably estimate long-term eGFR slopes is unknown. Furthermore, the impact of missing data on eGFR slope estimation is unclear.
METHODS: Data from the Cure Glomerulonephropathy (CureGN) study were used to answer two questions. A Total Duration question compared eGFR slope estimates based on shorter intervals of follow-up (FU) with true long-term slopes using descriptive statistics, overall and within patient subgroups based on age, disease diagnosis, disease activity at study enrollment and during FU, nonlinearity of the eGFR trajectory, and eGFR measurement frequency. A Duration after Missingness question simulated missing data to examine different lengths of FU time after initial gaps between biopsy and study enrollment to compare eGFR slope estimates with true complete-data eGFR slopes, overall and within patient subgroups.
RESULTS: For the Total Duration question, eGFR slope estimates gradually became more accurate with longer FU, with 86% of slopes based on 3.5-4 years of FU within 5 ml/min per 1.73 m 2 per year of true long-term slopes. For the Duration after Missingness question, 84% of eGFR slopes based on over 2 years of FU were within 5 ml/min per 1.73 m 2 per year of true complete-data slopes after initial missing data gaps between 6 and 24 months. For both questions, eGFR slopes stabilized faster for adults compared with children and for those diagnosed with membranous nephropathy or IgA nephropathy compared with minimal change disease or FSGS. For the Total Duration question, participants with nonlinear trajectories required much longer time to achieve stable eGFR slopes compared with those with linear trajectories.
CONCLUSIONS: Several years of FU are necessary to accurately estimate long-term eGFR slopes in patients with glomerular disease, but moderately sized gaps between eGFR measurements are acceptable.
BACKGROUND: Slope of eGFR is an important measurement of kidney disease progression and clinical outcome in glomerular disease. However, the length of time required to reliably estimate long-term eGFR slopes is unknown. Furthermore, the impact of missing data on eGFR slope estimation is unclear.
METHODS: Data from the Cure Glomerulonephropathy (CureGN) study were used to answer two questions. A Total Duration question compared eGFR slope estimates based on shorter intervals of follow-up (FU) with true long-term slopes using descriptive statistics, overall and within patient subgroups based on age, disease diagnosis, disease activity at study enrollment and during FU, nonlinearity of the eGFR trajectory, and eGFR measurement frequency. A Duration after Missingness question simulated missing data to examine different lengths of FU time after initial gaps between biopsy and study enrollment to compare eGFR slope estimates with true complete-data eGFR slopes, overall and within patient subgroups.
RESULTS: For the Total Duration question, eGFR slope estimates gradually became more accurate with longer FU, with 86% of slopes based on 3.5-4 years of FU within 5 ml/min per 1.73 m 2 per year of true long-term slopes. For the Duration after Missingness question, 84% of eGFR slopes based on over 2 years of FU were within 5 ml/min per 1.73 m 2 per year of true complete-data slopes after initial missing data gaps between 6 and 24 months. For both questions, eGFR slopes stabilized faster for adults compared with children and for those diagnosed with membranous nephropathy or IgA nephropathy compared with minimal change disease or FSGS. For the Total Duration question, participants with nonlinear trajectories required much longer time to achieve stable eGFR slopes compared with those with linear trajectories.
CONCLUSIONS: Several years of FU are necessary to accurately estimate long-term eGFR slopes in patients with glomerular disease, but moderately sized gaps between eGFR measurements are acceptable.